Podcast
Emerging Evidence in the Treatment of Obesity
Author(s):
In this episode of MEDcast, Diana Isaacs and Natalie Bellini interview Dr. Ken Fujioka, an endocrine specialist, to discuss practice guidelines on obesity treatment and the evolution of anti-obesity medications over the last decade.
To watch the video series component of this episode, click here.
1:20 Obesity-associated metabolic disturbances
5:37 When to start medication for obesity
8:28 Metabolic pathways leading to weight gain
13:19 Long-term impact of weight fluctuations
16:07 GLP-1 agonists for weight loss
20:26 Insurance coverage for anti-obesity medications (AOMs)
24:50 Combining lifestyle changes with AOMs
26:27 ‘Super-responders’ to GLP-1 agonist therapies
30:51 Non-responders to GLP-1 agonist therapies
37:28 Comprehensive approach to weight management
